Skip to main content
. 2019 May 2;9:6841. doi: 10.1038/s41598-019-43298-0

Figure 3.

Figure 3

IC-2 increases the production and secretion of matrix metalloproteinases (MMPs) in mesenchymal stem cells (MSCs). (A) mRNA expression of fibrolytic genes in MSCs on day 7 in vitro (n = 3, mean ± S.D., **P < 0.01, Student’s t-test). (B) In vitro activities of MMP-1 and MMP-14 in MSCs on day 7 (n = 3, mean ± S.D., **P < 0.01, one-way ANOVA, Tukey test). (C) Expression of MMPs in the secretome of MSCs in vitro. (D) Images of liver tissue used in the experiments and enzymatic activities of MMPs in liver tissues containing cell sheets. Data are expressed as activity relative to that in the CCl4(−) group. CCl4(−) indicates control mice without CCl4 intoxication. Images of liver tissues used in these experiments (left). MMP activities (middle) and activities of total MMPs (right), consisting of active enzyme and latent pro-enzyme (n = 6, mean ± S.E.M., *P < 0.05, **P < 0.01, one-way ANOVA, Games–Howell test). (E) Linear regression analysis of relative activities of active MMP-1 (left) or active MMP-14 (right) with respect to hepatic hydroxyproline content 9 days after transplantation (n = 12, Pearson’s correlation coefficient).